Claims
- 1. Process for the preparation of 2,2-R.sub.1,R.sub.2 -1,3-dioxolane-4methanol enriched in R-isomer wherein R.sub.1 and R.sub.2 are H or alkyl groups, optionally branched, or wherein R.sub.1 and R.sub.2 together with the carbon atom to which they are attached form a carbocyclic ring which comprises subjecting a mixture of R- and S-2,2-R.sub.1,R.sub.2 -1,3-dioxolane-4-methanol to the action of a bacteria selected from the group consisting of the genus Nocardia, the genus Rhodococcus, the genus Corynabacterium and the genus Mycobacterium having the ability for stereoselective consumption of S-2,2-R.sub.1,R.sub.2 -1,3dioxolane-4-methanol for a period of time such that S-2,2-R.sub.1,R.sub.2 -1,3-dioxolane-4-methanol in the mixture is altered to give a 2,2-R.sub.1,R.sub.2 -1,3-dioxolane-4-methanol enriched in R-isomer.
- 2. Process according to claim 1 wherein the period of time is such that at least 80% of S-2,2-R.sub.1,R.sub.2 -1,3-dioxolane-4-methanol is altered.
- 3. Process according to claim 2 wherein the period of time is such that at least 90% of S-2,2-R.sub.1,R.sub.2 -1,3-dioxolane-4-methanol is altered.
- 4. Process according to claim 1 wherein substantially pure R-2,2-R.sub.1,R.sub.2 -1,3-dioxolane-4-methanol is produced.
- 5. Process according to claim 1 wherein the alkyl groups contain less than 6 carbon atoms or wherein the carbocyclic ring contains less than 8 carbon atoms.
- 6. Process according to claim 1 wherein R.sub.1 and R.sub.2 are identical.
- 7. Process according to claim 1 wherein R.sub.1 and R.sub.2 are H or an alkyl group containing 1-3 carbon atoms or together with the carbon atom to which they are attached form a carbocyclic ring containing 5 or 6 carbon atoms.
- 8. Process according to claim 1 wherein the micro-organism used in Rhodococcus equi selected from the group consisting of Rhodococcus equi NCIB 12035 or Rhodococcus equi (IFO 03730).
- 9. Process according to claim 1 wherein the micro-organism used is Rhodococcus rhodochrous selected from the group consisting of Rhodococcus rhodochrous (NCIB 9703) or Rhodococcus rhodochrous (ATCC 21197).
- 10. Process according to claim 1 wherein the micro-organism used is Rhodococcus erythropolis selected from the group consisting of Rhodococcus erythropolis SCL 38-2 (CBS 179.86) Rhodococcus erythropolis SCL 38-2R (CBS 180.86) or Rhodococcus erythropolis SCL 38-2S (CBS 181.86).
- 11. Process according to claim 1 wherein the micro-organism used is Corynebacterium equi selected from the group consisting of Corynebacterium equi A 2362 (CBS 264.87) or Corynebacterium equi A 2431 (CBS 263.87).
- 12. Process according to claim 1 wherein the micro-organism used is Corynebacterium alkanum (ATCC 21194).
- 13. Process according to claim 1 wherein the micro-organism used is Corynebacterium hydrocarboclastus (ATCC 15108).
- 14. Process according to claim 1 wherein the micro-organism used is Corynebacterium sp. DS 5122 (CBS 265.87) or Corynebacterium sp. T 1300 (CBS 267.87).
- 15. Process according to claim 1 wherein the micro-organism used is Nocardia erythropolis selected from the group consisting of Nocardia erythropolis T 487 (NCIB 9158), Nocardia erythropolis (DSM 743) or Nocardia erythropolis (ATCC 4277).
- 16. Process according to claim 1 wherein the micro-organism used is Nocardia corallina (ATCC 31338).
- 17. Process according to claim 1 wherein the micro-organism used is Nocardia canicruria (ATCC 31548).
- 18. Process according to claim 1 wherein the micro-organism used is Nocardia paraffinae (NCIB 11277).
- 19. Process according to claim 1 wherein the micro-organism used is Nocardia spec. DS 5123 (CBS 266.87).
- 20. Process according to claim 1 wherein the micro-organism used is Nocardia aurantia (NCIB 9557).
- 21. Process according to claim 1 wherein the micro-organism used is Nocardia calcarea (NCIB 8863).
- 22. Process according to claim 1 wherein the micro-organism used is Nocardia cathaarde T 985 (CBS 268.87).
- 23. Process according to claim 1 wherein the micro-organism used is Nocardia globerula (NCIB 9159).
- 24. Process according to claim 1 wherein the micro-organism used is Nocardia ragosa (NCIB 8926).
- 25. Process according to claim 1 wherein the micro-organism used is Mycobacterium rhodochrous (NCIB 11061).
- 26. Process according to claim 1 wherein said bacteria is immobilized either as a living cell, as a killed cell or as a resting cell.
- 27. Process according to claim 1, wherein the S-2,2-R.sub.1,R.sub.2 -1,3-dioxolane-4-methanol is substantially converted into R-2,2-R.sub.1,R.sub.2 -1,3-dioxolane-4-carboxylic acid.
- 28. The process of claim 1, wherein R.sub.1 and R.sub.2 are methyl groups, and wherein the process further comprises a step wherein the R-isomer enriched product is converted to metaprolol enriched in the S isomer.
- 29. The process of claim 27, further comprising the steps of separating the R-isomer enriched 2,2-R.sub.1,R.sub.2 -1,3-dioxolane-4-carboxylic acid from the R-isomer enriched 2,2-R.sub.1,R.sub.2 -dioxolane-4-methanol, and converting the R-isomer enriched 2,2-R.sub.1 R.sub.2 -1,3dioxolane-4-carboxylic acid into S-isomer enriched 2,2-R.sub.1 R.sub.2 -dioxolane-4-methanol.
Priority Claims (1)
Number |
Date |
Country |
Kind |
8611238 |
May 1986 |
GBX |
|
Parent Case Info
This is a continuation of Ser. No. 07/047,908, filed May 7, 1987, now abandoned.
US Referenced Citations (2)
Number |
Name |
Date |
Kind |
4772749 |
Karrenbauer et al. |
Sep 1988 |
|
4812406 |
Takahashi et al. |
Mar 1989 |
|
Continuations (1)
|
Number |
Date |
Country |
Parent |
47908 |
May 1987 |
|